Last CNY8.25 CNY
Change Today +0.03 / 0.36%
Volume 1.4M
As of 3:00 AM 04/18/14 All times are local (Market data is delayed by at least 15 minutes).

northeast pharmaceutical-a (000597) Snapshot

Open
CNY8.25
Previous Close
CNY8.22
Day High
CNY8.25
Day Low
CNY8.13
52 Week High
02/28/14 - CNY9.05
52 Week Low
06/25/13 - CNY5.19
Market Cap
2.8B
Average Volume 10 Days
2.5M
EPS TTM
CNY-0.51
Shares Outstanding
333.8M
EX-Date
05/2/13
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NORTHEAST PHARMACEUTICAL-A (000597)

Related News

No related news articles were found.

northeast pharmaceutical-a (000597) Related Businessweek News

No Related Businessweek News Found

northeast pharmaceutical-a (000597) Details

Northeast Pharmaceutical Group Co., Ltd. provides chemical synthetic and bio-fermentation APIs, and medicinal and micro-ecological preparation products in China. The company provides various nutritional products, such as Vitamin C, L-Carnitine, and other products for customers in food, beverage, and health industries; API products, such as fosfomycin, anti HIV, and other products; and chemical products, including chemical and pharmaceutical intermediates, and chiral separation reagent products. It also offers healthcare products, such as dietary supplements; prescription and OTC products, including antibiotics and antibacterials, narcotic and psychoactive drugs, antipyretic analgesics, antivirus, cardio-cerebral-vascular drugs, anti-allergic drugs, gastrointestinal drugs, gynecological drugs, psychiatric drugs, antitussive diabetes drugs, urological drugs, and other products; and OEM products comprising effervescent tablets, coated tablets, and caplets. In addition, the company distributes various medical products, such as vitamins, amino acids, nutrition supplements, sweetness, etc. in North and South Americas, Europe, Africa, South-East Asia, etc. Northeast Pharmaceutical Group Co., Ltd. is based in Shengyang, the People’s Republic of China.

northeast pharmaceutical-a (000597) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

northeast pharmaceutical-a (000597) Key Developments

Northeast Pharmaceutical Group Co., Ltd. to Report Fiscal Year 2013 Results on Mar 28, 2014

Northeast Pharmaceutical Group Co., Ltd. announced that they will report fiscal year 2013 results on Mar 28, 2014

Northeast Pharmaceutical Group Co., Ltd., Special/Extraordinary Shareholders Meeting, Dec 03, 2013

Northeast Pharmaceutical Group Co., Ltd., Special/Extraordinary Shareholders Meeting, Dec 03, 2013., at 13:30 China Standard Time. Agenda: To consider write-off of assets loss resulted from relocation of No. 212 workshop of the company; to change of financial audit firm; to change of internal control audit firm and the company's eligibility for non-public offering to specific parties.

Northeast Pharmaceutical Group Co., Ltd. to Report Q3, 2013 Results on Oct 25, 2013

Northeast Pharmaceutical Group Co., Ltd. announced that they will report Q3, 2013 results on Oct 25, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000597:CH CNY8.25 CNY +0.03

000597 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000597.
View Industry Companies
 

Industry Analysis

000597

Industry Average

Valuation 000597 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.7x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NORTHEAST PHARMACEUTICAL-A, please visit www.negpf.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.